We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOBL
2126
DELISTED
MobileIron, Inc.
MOBL
| $3.85M | ﹤0.01% |
791,860
+38,691
| +5% | +$206K |
|
2127
ANI Pharmaceuticals
ANIP
$1.78B
| $3.81M | ﹤0.01% |
61,863
-5,056
| -8% | -$335K |
|
|
MAXR
2128
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $3.81M | ﹤0.01% |
243,190
-41,410
| -15% | -$430K |
|
|
BPFH
2129
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.8M | ﹤0.01% |
316,110
-6,100
| -2% | -$70.7K |
|
|
OSG
2130
Octave Specialty Group
OSG
$222M
| $3.8M | ﹤0.01% |
176,222
-3,296
| -2% | -$67.6K |
|
2131
Vicor
VICR
$10.2B
| $3.79M | ﹤0.01% |
81,172
+12,159
| +18% | +$463K |
|
2132
RadNet
RDNT
$5.69B
| $3.78M | ﹤0.01% |
186,361
-45,794
| -20% | -$785K |
|
|
TDAY
2133
USA Today Co
TDAY
$1.06B
| $3.77M | ﹤0.01% |
591,097
+253,563
| +75% | +$1.86M |
|
2134
Cerus
CERS
$474M
| $3.77M | ﹤0.01% |
892,290
+231,849
| +35% | +$999K |
|
2135
Weibo
WB
$1.95B
| $3.77M | ﹤0.01% |
81,216
-12,312
| -13% | -$576K |
|
2136
Red Robin
RRGB
$152M
| $3.76M | ﹤0.01% |
113,934
+13,013
| +13% | +$384K |
|
2137
Marcus & Millichap
MMI
$1.19B
| $3.76M | ﹤0.01% |
100,921
-2,947
| -3% | -$106K |
|
2138
Standex International
SXI
$4.12B
| $3.75M | ﹤0.01% |
47,269
-1,001
| -2% | -$76.1K |
|
|
HAPN
2139
Happen Inc
HAPN
$2.24B
| $3.73M | ﹤0.01% |
295,648
-293,294
| -50% | -$3.78M |
|
2140
Hyster-Yale Materials Handling
HY
$665M
| $3.72M | ﹤0.01% |
63,130
-7,190
| -10% | -$400K |
|
2141
Standard BioTools
LAB
$314M
| $3.72M | ﹤0.01% |
1,069,498
-120,720
| -10% | -$425K |
|
2142
W&T Offshore
WTI
$518M
| $3.69M | ﹤0.01% |
664,489
-766
| -0.1% | -$3.41K |
|
2143
Artivion
AORT
$1.32B
| $3.69M | ﹤0.01% |
136,330
-41,609
| -23% | -$1.02M |
|
2144
BioCryst Pharmaceuticals
BCRX
$2.4B
| $3.69M | ﹤0.01% |
1,068,498
+245,616
| +30% | +$618K |
|
|
WPG
2145
DELISTED
Washington Prime Group Inc.
WPG
| $3.65M | ﹤0.01% |
111,537
-2,434
| -2% | -$88.3K |
|
2146
Shutterstock
SSTK
$219M
| $3.65M | ﹤0.01% |
85,060
+511
| +0.6% | +$20.5K |
|
2147
Evolent Health
EVH
$447M
| $3.65M | ﹤0.01% |
402,790
+4,147
| +1% | +$33.7K |
|
2148
Amneal Pharmaceuticals
AMRX
$5.79B
| $3.64M | ﹤0.01% |
754,424
+366,995
| +95% | +$1.28M |
|
|
DERM
2149
DELISTED
Dermira, Inc.
DERM
| $3.63M | ﹤0.01% |
239,800
+71,692
| +43% | +$619K |
|
2150
Koppers
KOP
$969M
| $3.63M | ﹤0.01% |
94,989
-89,311
| -48% | -$3.14M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.